SCHEMBL5407413

SCHEMBL5407413

CC(C)(C)OC(=O)COC(c1ccccc1)C(OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CASR P41180 1/20 0.39
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ SLC6A4 P31645 2/20 0.38
▸ SLC6A3 Q01959 2/20 0.38
▸ SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5407416 1.00 CYP1A1 (0.42) CYP1A1CYP19A1TSHRALDH1A1HSD17B10
SCHEMBL14578329 1.00 CYP1A1 (0.42) CYP1A1CYP19A1TSHRALDH1A1HSD17B10
SCHEMBL14578330 0.81 CTSS (0.39) ALDH1A1MAPTCYP2D6SLC6A4SLC6A3
SCHEMBL9292110 0.77 CTSS (0.42) TSHRCASRCYP2D6SLC6A4SLC6A3
SCHEMBL16672751 0.76 L3MBTL1 (0.41) MEN1KMT2A
SCHEMBL2691863 0.75 MAPK1 (0.53) TSHRALDH1A1HSD17B10TDP1MEN1
SCHEMBL5082131 0.73 TSHR (0.50) TSHRALDH1A1HSD17B10TDP1TP53
SCHEMBL16713307 0.73 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ACASR
SCHEMBL6861277 0.73 SERPINE1 (0.48) TSHRALDH1A1HSD17B10TDP1TP53
SCHEMBL1082231 0.72 TSHR (0.53) CYP1A1CYP19A1TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173141-B2 Chiral lactones COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2007-02-06 — — US disclosed
US-20060205816-A1 Chiral lactones COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2006-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205816-A1 Chiral lactones HSD11B2, HSD11B1, HSD17B2 CYP1A1 70/4885CYP19A1 30/4885TSHR 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback